TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tryptamine Therapeutics ( (AU:TYP) ) has issued an update.
Tryptamine Therapeutics Limited has announced the cessation of certain securities, specifically options that expired without being exercised or converted. This cessation involves a total of 1.8 million options with varying exercise prices. The announcement may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies.
More about Tryptamine Therapeutics
Average Trading Volume: 2,505,731
Technical Sentiment Signal: Buy
Current Market Cap: A$51.98M
For an in-depth examination of TYP stock, go to TipRanks’ Overview page.